We are developing NextGen tests and panels to assess patients with chest pain.
3-plex Cardiac Panel
Diagnosis or rule-out heart attack
Diagnosis and prognosis of heart failure
Diagnosis or rule-out pulmonary embolism (clots in the lungs) in patients with shortness of breath
High-sensitivity Troponin for Heart Attack
Our first test in the cardiac marker product line will be a NextGen test for heart attack: a high-sensitivity troponin test that will enable faster diagnosis of heart attack or rule-out/discharge of low-risk patients. Safe discharge reduces unnecessary hospital admissions, reduces crowding in the emergency department and cuts costs to the healthcare system significantly.
Emergency physicians need sensitive, precise lab results to guide treatment or safe discharge for patients with chest pain. Professional guidelines are driving the shift to high-sensitivity troponin assays, which can diagnose or rule-out heart attack 4-6 hours earlier than contemporary tests.
Central lab tests suffer from turnaround time of 60 to 90 minutes or more. Point-of-care tests are fast and widely used, but the, care team must compromise performance for speed.
The Brava™ hs-Troponin Test will deliver lab-quality performance at the point-of-care in 15 minutes.
NT-proBNP for Heart Failure Assessment
Approximately 6.2 million Americans have heart failure, there are 1 million new cases diagnosed each year and over 78,000 deaths annually. Prevalence will increase to more than 8 million people by 2030 and the total cost of heart failure is expected to grow to nearly $70 billion in the U.S. as the population ages.
With statistics like these, emergency departments need better tools to assess patients with shortness of breath and other symptoms of heart failure. We are developing a 3-plex test with high-sensitivity troponin, NT-proBNP and D-dimer in the Brava Cardiac Panel that will deliver actionable results in 15 minutes.
D-Dimer for Pulmonary Embolism
Pulmonary embolism (PE) usually presents as shortness of breath, a symptom common with heart attack and heart failure. PE is a life-threating blood clot in the lung, usually arising from deep vein thrombosis (DVT), or clots in the legs. A D-dimer test can be used to rule out PE or DVT.
Products are under development and not available for sale.